Details for 2012874745
Up to date per 04.04.2026
Actions
Details for 2012874745
Granted/Registered
European Patent
18.03.2015 A
08.02.2017 B1
20.04.2012
US
201261636256 P
A61K 31/216 20060101AFI20150716BHEP
Owner
Immedica Pharma ABNorrtullsgatan 15113 29 StockholmSE
Representative
Representative
Haffner & Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT
Inventor
SCHARSCHMIDT, Bruce45 St. Francis Boulevard San Francisco, California 94127US
MOKHTARANI, Masoud725 Castle Rock Road Walnut Creek, California 94598US
Information about Fees